ethyl 2-(4-(2-bromoacetyl)phenyl)-2-methylpropanoate

1,3,3-Trimethyl-piperazine

5,8-dihydroxynaphthalene-1,4-dione

2-(phenyliodonio)benzoate

2-chloro-6-nitrobenzaldehyde

Tannins (03C, 04C, 05C, 08C, 09C, 10C, 11C, 12C, 13C, 14C, 15C, 16C)

2-(bromomethyl)-1-chloro-3-nitrobenzene

5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-Pyrrole-3-carboxamide phosphate (1:1)

(6R,7S)-3-((carbamoyloxy)methyl)-7-methoxy-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, sodium salt

(8R,9S,10S,13R,14S,17R)-17-((2R,5R)-5,6-dimethylheptan-2-yl)-10,13-dimethyl-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol

Lifitegrast

(6R,7R)-3-((4-carbamoylpyridin-1-ium-1-yl)methyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

monopotassium mono(dioxidodioxoosmium) hydrate

dimethyl nonanedioate

N-Acetyl-α-D-galactosamine

2-((tert-butyldimethylsilyl)oxy)ethyl trifluoromethanesulfonate

4-[4-[[[[4-chloro-3-((trifluoromethyl))phenyl]amino]carbonyl]amino]phenoxy]-N-methylpyridin-2-carboxamide tosylate (1:1)

methyl 5-bromo-1H-pyrrole-2-carboxylate

4-[(4-fluoro-2-methyl-1H-indol-5-yloxy)]-6-methoxy-7-[3-(pyrrolidin-1-yl)-propoxy]-Quinazoline

Estrogen receptor antagonist 2